Annual SGA
$1.33 M
+$428.98 K+47.50%
September 30, 2024
Summary
- As of March 8, 2025, HQL annual SGA is $1.33 million, with the most recent change of +$428.98 thousand (+47.50%) on September 30, 2024.
- During the last 3 years, HQL annual SGA has risen by +$488.10 thousand (+57.83%).
- HQL annual SGA is now at all-time high.
Performance
HQL SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
N/A
September 30, 2024
Summary
- HQL quarterly SGA is not available.
Performance
HQL Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM SGA
$74.32 M
+$45.61 M+158.86%
September 30, 2024
Summary
- As of March 8, 2025, HQL TTM SGA is $74.32 million, with the most recent change of +$45.61 million (+158.86%) on September 30, 2024.
- HQL TTM SGA is now -63.75% below its all-time high of $205.04 million.
Performance
HQL TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
HQL Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +47.5% | - | - |
| 3 y3 years | +57.8% | - | - |
| 5 y5 years | - | - | +10000.0% |
HQL Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +57.8% | -63.8% | +193.2% | ||
| 5 y | 5-year | at high | +57.8% | -63.8% | +193.2% | ||
| alltime | all time | at high | +57.8% | -63.8% | +193.2% |
Tekla Life Sciences Investors Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | $1.33 M(+47.5%) | - | - |
| Sep 2023 | $903.14 K(-16.1%) | - | - |
| Sep 2022 | $1.08 M(+27.6%) | - | - |
| Sep 2021 | $844.02 K | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $375.89 K(-10.8%) | $797.51 K(+89.2%) |
| Sep 2019 | - | $421.62 K(>+9900.0%) | $421.62 K(+6.4%) |
| Mar 2019 | - | $0.00(-100.0%) | $396.20 K(0.0%) |
| Sep 2018 | - | $396.20 K | $396.20 K |
FAQ
- What is Tekla Life Sciences Investors annual SGA?
- What is the all time high annual SGA for Tekla Life Sciences Investors?
- What is Tekla Life Sciences Investors annual SGA year-on-year change?
- What is the all time high quarterly SGA for Tekla Life Sciences Investors?
- What is Tekla Life Sciences Investors TTM SGA?
- What is the all time high TTM SGA for Tekla Life Sciences Investors?
What is Tekla Life Sciences Investors annual SGA?
The current annual SGA of HQL is $1.33 M
What is the all time high annual SGA for Tekla Life Sciences Investors?
Tekla Life Sciences Investors all-time high annual SGA is $1.33 M
What is Tekla Life Sciences Investors annual SGA year-on-year change?
Over the past year, HQL annual SGA has changed by +$428.98 K (+47.50%)
What is the all time high quarterly SGA for Tekla Life Sciences Investors?
Tekla Life Sciences Investors all-time high quarterly SGA is $421.62 K
What is Tekla Life Sciences Investors TTM SGA?
The current TTM SGA of HQL is $74.32 M
What is the all time high TTM SGA for Tekla Life Sciences Investors?
Tekla Life Sciences Investors all-time high TTM SGA is $205.04 M